Antibodies play an essential role in host defence against pathogens by recognizing microorganisms
or infected cells. Although preventing pathogen entry is one potential mechanism of …

While a third of the world carries the burden of tuberculosis, disease control has been hindered
by a lack of tools, including a rapid, point-of-care diagnostic and a protective vaccine. In …

Exposure to Mycobacterium tuberculosis (Mtb) results in heterogeneous clinical outcomes
including primary progressive tuberculosis and latent Mtb infection (LTBI). Mtb infection is …

Each severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant renews concerns
about decreased vaccine neutralization weakening efficacy. However, while prevention …

Background Mycobacterium tuberculosis remains a global health problem and clinical
management is complicated by difficulty in discriminating between latent infection and active …

V accessory proteins from Paramyxoviruses are important in viral evasion of the innate immune
response. Here, using a cell survival assay that identifies both inhibitors and activators of …

Maternal immunity impacts the infant, but how is unclear. To understand the implications of
the immune exposures of vaccination and infection in pregnancy for neonatal immunity, we …

Despite over a century of research, Mycobacterium tuberculosis (Mtb), the causative agent
of tuberculosis (TB), continues to kill 1.5 million people annually. Though less than 10% of …

With an estimated 25% of the global population infected with Mycobacterium tuberculosis (Mtb),
tuberculosis (TB) remains a leading cause of death by infectious diseases. Humoral …

Mycobacterium tuberculosis (Mtb) resides in a quarter of the world's population and is the
causative agent for tuberculosis (TB), the most common infectious reason of death in humans …